Pdt Partners, LLC Bristol Myers Squibb CO Transaction History

Pdt Partners, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$63.71 - $70.74 $809,117 - $898,397	-12,700 Reduced 49.8%	12,800 $818,000
Q1 2023 May 15, 2023	BUY	$65.71 - $74.53 $1.68 Million - $1.9 Million	25,500 New	25,500 $1.77 Million
Q1 2022 May 16, 2022	SELL	$61.48 - $73.72 $940,644 - $1.13 Million	-15,300 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$53.63 - $62.52 $820,539 - $956,556	15,300 New	15,300 $954,000
Q1 2020 May 15, 2020	SELL	$46.4 - $67.43 $7.78 Million - $11.3 Million	-167,703 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$49.21 - $64.19 $23.5 Million - $30.7 Million	-478,197 Reduced 74.04%	167,703 $10.8 Million
Q3 2019 Nov 14, 2019	SELL	$42.77 - $50.71 $1,454 - $1,724	-34 Reduced 0.01%	645,900 $32.8 Million
Q2 2019 Aug 14, 2019	SELL	$44.62 - $49.34 $2,677 - $2,960	-60 Reduced 0.01%	645,934 $29.3 Million
Q1 2019 May 15, 2019	BUY	$45.12 - $53.8 $29.1 Million - $34.8 Million	645,994 New	645,994 $30.8 Million
Q2 2018 Aug 14, 2018	SELL	$50.53 - $62.98 $11.8 Million - $14.8 Million	-234,430 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$59.92 - $68.98 $1.87 Million - $2.16 Million	-31,251 Reduced 11.76%	234,430 $14.8 Million
Q4 2017 Feb 14, 2018	BUY	$59.94 - $65.35 $2.9 Million - $3.16 Million	48,351 Added 22.25%	265,681 $16.3 Million
Q3 2017 Nov 14, 2017	BUY	$55.23 - $63.74 $12 Million - $13.9 Million	217,330	217,330 $13.9 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Pdt Partners, LLC with notifications on news.